Active Substance Master File (ASMF) worksharing procedure

Size: px
Start display at page:

Download "Active Substance Master File (ASMF) worksharing procedure"

Transcription

1 Active Substance Master File () worksharing Working Group Nienke Rodenhuis September Table of Contents Why needed History How does it work Status Support 2 2

2 Why do we need a worksharing for s? When the same is used in multiple s and/or Member States, it can lead to Duplicated Divergent decisions Frequent updates (at NCA request) Reduced oversight of the Increased workload (all parties) 3 3 What has been done to solve the problem? Assessment Worksharing Procedure A simple way for Competent Authorities to share report for the same version of the Letter of Access 1 Submission Details Form 2 report repository EU/ repository number 1 Annex 2 and 2 Annex 3 of CHMP/QWP/227/02 Rev 3/Corr Guideline on the 4 4

3 History Goal: There should be 1 for Used in national, MRP/DCP and CP, variations For human & veterinary products April 2010 : discussion in HMA June 2010 : first meeting of -WG April 2011 : meeting with interested parties and HMA decision December 2013 : start of pilot-phase January 2017 : end of pilot-phase, worksharing is business as usual 5 5 Collaboration Members: All EU national competent authorities Observers : EDQM, IGDRP Continuous interaction with stakeholders At QWP plenary meetings (intra-network) At bimonthly WG meetings (intra-network) holders taking part in WS and Interested Parties (AESGP, EFPIA, EGA, EUCOPE, APIC/CEFIC, IFAH, EGGVP) 6 6

4 How does the worksharing work? EU/ repository number + Submission Details Form Tracks where the same version of the is used in different s & Member States report repository allows Competent Authorities to share easily the report ( holder acknowledges sharing of reports in the Letter of Access) 7 7 How does the worksharing work? Designed to operate within existing legislation, regulatory s and timetables NO IMPACT ON PROCEDURE TIMINGS Reduces CA requests for updates Harmonises Improves oversight of the Reduces workload & MA holders (plus Competent Authorities) 8 8

5 The worksharing Includes New s submitted in DCP, CAP or national marketing authorisation applications and variation applications Undergoing / previously assessed in a DCP/MRP/CAP NB: s undergoing or have been assessed in national only s may still be accepted in the worksharing, but may result in a new evaluation of the. holders should list these applications in the Submission Details Form so that the report may be requested and used in the evaluation. NB: If the same data have been submitted in a CEP application, holders should notify Competent Authorities so that the report may be requested from the EDQM Updates to a worksharing can be submitted in a MA or MAV application using any regulatory in order to preserve its lifecycle Use of the is strongly recommended, but not mandatory 9 9 The worksharing Assessments of new s composed of 2 to 3 stages -AR repository uses timetables to identify parent Other s are Daughter s Parent is responsible for drafting report QA review of the report by Parent CMS/Daughter RMS Review of report by Parent CMS Only Major Objections raised during reviews Procedure repeats as above until is complete 10 10

6 Current number of s in Worksharing Status August 2017: Number of -numbers issued : 128 Accepted for use ( finalised) : 40 Under evaluation : 58 Reserved : 26 s withdrawn : What support is available? Relevant to worksharing and worksharing s Applicable to all s Assessment worksharing guidance Guidance on CMD Q&As on worksharing Training on the worksharing CMD Q&As on Additional guidance on documents Completing & submitting annex 2, 3 &

7 Links to support documents Guideline on the (CHMP/QWP/227/02/Rev3/Corr) Additional guidance on documents relating to an active substance master file CMD Q&As on the + Q3.4 of the CMD Q&A on Variations (concerning updates) The worksharing Training material on the worksharing CMD Q&As on the worksharing What support is available? For issues concerning the work sharing, please contact the CMD Working Group on s H-CMDhSecretariat@ema.europa.eu The subject header of the should clearly state worksharing 14 14

1 The EU Harmonised technical ectd guidance version 4.0

1 The EU Harmonised technical ectd guidance version 4.0 Annex 2 to the HMA esubmission Roadmap: Implementation of mandatory ectd format for regulatory submissions (Status: Final version adopted by the esubmission CMB. Dated 26 July 2016) Scope This annex is

More information

Annex 2 to the HMA esubmission Roadmap: Implementation of mandatory use of ectd format for regulatory submissions

Annex 2 to the HMA esubmission Roadmap: Implementation of mandatory use of ectd format for regulatory submissions 10 March 2017 Annex 2 to the HMA esubmission Roadmap: Implementation of mandatory use of ectd format for regulatory submissions Status: Final updated version adopted by the esubmission CMB Scope This annex

More information

The place of the Certification procedure in 2017 in the EU regulatory framework and beyond. Prague, 19 September 2017

The place of the Certification procedure in 2017 in the EU regulatory framework and beyond. Prague, 19 September 2017 The place of the Certification procedure in 2017 in the EU regulatory framework and beyond Prague, 19 September 2017 Hélène BRUGUERA Head of the Certification Department, EDQM, Council of Europe CEPs in

More information

esubmission roadmap v2.0: Industry viewpoint

esubmission roadmap v2.0: Industry viewpoint TOPRA Veterinary Medicines Symposium 2017 esubmission roadmap v2.0: Industry viewpoint Patrizia Oelker Boehringer Ingelheim Animal Health ENABLING AND PROMOTING EXCELLENCE IN THE HEALTHCARE REGULATORY

More information

Recommendation on duplicate applications in mutual recognition and decentralised procedures

Recommendation on duplicate applications in mutual recognition and decentralised procedures EMA/CMDv/210123/2010 CMDv/GUI-010 Recommendation on duplicate applications in mutual recognition and decentralised procedures Edition number: 1 Edition date: 11 April 2014 Implementation date: 16 January

More information

CMDv/BPG/002. BEST PRACTICE GUIDE for Veterinary Decentralised Procedure (DCP)

CMDv/BPG/002. BEST PRACTICE GUIDE for Veterinary Decentralised Procedure (DCP) BEST PRACTICE GUIDE for Veterinary Decentralised Procedure (DCP) Edition number: 05 Edition date: 7 November 2013 Implementation date: 6 February 2006 CMDv Secretariat: 7 Westferry Circus, Canary Wharf,

More information

BEST PRACTICE GUIDE FOR DECENTRALISED AND MUTUAL RECOGNITION PROCEDURES

BEST PRACTICE GUIDE FOR DECENTRALISED AND MUTUAL RECOGNITION PROCEDURES BEST PRACTICE GUIDE FOR DECENTRALISED AND MUTUAL RECOGNITION PROCEDURES Doc. Ref.: CMDh/068/1996/Rev.10 April 2013 INTRODUCTION 1. Competent authorities should ensure that their assessment reports are

More information

Report from the CMDh meeting held on November 2013

Report from the CMDh meeting held on November 2013 Report from the meeting held on 18-20 November 2013 Pharmacovigilance Outcomes of informal PSUR work-sharing procedures The has adopted the conclusions of PSUR assessment for alprostadil, ciclosporin,

More information

Report on status of on-going Article 45 & 46 work-sharing procedure. Shirley NORTON MHRA (UK) Alban DHANANI AFSSAPS (FR)

Report on status of on-going Article 45 & 46 work-sharing procedure. Shirley NORTON MHRA (UK) Alban DHANANI AFSSAPS (FR) Report on status of on-going Article 45 & 46 work-sharing procedure Shirley NORTON MHRA (UK) Alban DHANANI AFSSAPS (FR) Why a worksharing? Making information available for healthcare professionals by publication

More information

The New EU PV Legislation: View from the European Commission

The New EU PV Legislation: View from the European Commission The New EU PV Legislation: View from the European Commission International seminar 26 May 2011 Lenita LINDSTRÖM Senior Policy Officer Pharmaceuticals Unit/DG SANCO Rationale for the revision Calls for

More information

EDQM roadmap for electronic submissions

EDQM roadmap for electronic submissions EDQM roadmap for electronic submissions Cornelia Bigler Weber scientific assistant Certification Department, EDQM 19 September 2017 1 Agenda esubmissions Roadmap for CEP applications with its major changes

More information

PSUR and PSUR repository. Legal basis. PSUR/PBRER General comments

PSUR and PSUR repository. Legal basis. PSUR/PBRER General comments PSUR and PSUR repository Mag. Dr. Irmgard Resch Dep. Assessment Pharmacovigilance AGES-Gespräche Vienna, 22.9.2015 www.basg.gv.at Österreichische Agentur für Gesundheit und Ernährungssicherheit GmbH Legal

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Referral procedures in accordance with the provisions of Articles 33(4), 34 and 35 of Directive 2001/82/EC, and Article 13 of Commission Regulation (EC) No 1234/2008,

More information

Adopted by Pharmacovigilance Risk Assessment Committee 20 February Adopted by Pharmacovigilance Inspectors Working Group 21 March 2014

Adopted by Pharmacovigilance Risk Assessment Committee 20 February Adopted by Pharmacovigilance Inspectors Working Group 21 March 2014 21 March 2014 EMA/INS/PhV/192231/2014 Union procedure on the management of pharmacovigilance inspection findings which may impact the robustness of the benefit-risk profile of the concerned medicinal Adopted

More information

General FAQ relating to e-submission for Veterinary Applications

General FAQ relating to e-submission for Veterinary Applications Veterinary Harmonisation Group July 2017 General FAQ relating to e-submission for Veterinary Applications 1. GENERAL QUESTIONS 1.1. What is an electronic submission for veterinary medicinal products? 1.2.

More information

Guide to Renewal of Veterinary Product Authorisations

Guide to Renewal of Veterinary Product Authorisations Guide to Renewal of Veterinary Product Authorisations AUT-G0024-3 04 JANUARY 2018 This guide does not purport to be an interpretation of law and/or regulations and is for guidance purposes only. CONTENTS

More information

...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS

...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS ...FREEDOM TO EXPLORE YOUR REGULATORY NEEDS 1 Table of Contents Pg 3 Pg 4 Pg 5 About Ivowen Limited Meet the team Pharmaceutical Regulatory Affairs Services: Human & Veterinary Pg 5 Pg 5 National Procedures

More information

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS

EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL TEXTS FOR USE IN THE ICH REGIONS INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 9 October 2017 2017 EMA/118465/2012 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module XV Safety communication (Rev 1) Date for coming into effect of first version 24 January 2013 Draft

More information

Article 29(1) Referral

Article 29(1) Referral Article 29(1) Referral DI(FH) Eva Pregernig, MSc AGES MEA, LCM, MRAT Article 29(1) CMDh Referral Agenda What is an Article 29(1) CMDh Referral What can be done if PSRPH are raised? The CMDh Referral Procedure

More information

Implementation of the new pharmacovigilance legislation: Overall update and activities in 2013

Implementation of the new pharmacovigilance legislation: Overall update and activities in 2013 Implementation of the new pharmacovigilance legislation: Overall update and activities in 2013 Workshop for micro, small and medium-sized enterprises (SMEs) European Medicines Agency (EMA), London 26 April

More information

Detailed guidance for National Scientific- Technical Advice (STA) requests:

Detailed guidance for National Scientific- Technical Advice (STA) requests: Federal agency for medicines and health products Eurostation II - Place Victor Horta 40/40 1060 Brussels www.afmps.be DG PRE Marketing Authorisation Detailed guidance for National Scientific- Technical

More information

Good Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA

Good Pharmacovigilance Practice. Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA Good Pharmacovigilance Practice Overview of GVP Modules on ADR, PSURs, Signal Management and Additional Monitoring Mick Foy - MHRA Content ADR Reporting Definition & Increased scope Transition arrangements

More information

Overview of ICH. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use.

Overview of ICH. International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use. Overview of ICH June 2018 International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use ICH Legal notice Legal Notice This presentation is protected by copyright and

More information

NEW FRAMEWORK FOR SCIENTIFIC ADVICE & PROTOCOL ASSISTANCE

NEW FRAMEWORK FOR SCIENTIFIC ADVICE & PROTOCOL ASSISTANCE European Medicines Agency Pre-authorisation Evaluation of Medicines for Human Use EMEA/267187/2005/ Rev. 1 London, 26 April 2006 NEW FRAMEWORK FOR SCIENTIFIC ADVICE & PROTOCOL ASSISTANCE The CPMP/CHMP

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

Feedback on SADC Workshop of Industry & Regulators. Luther Gwaza PhD Consultant

Feedback on SADC Workshop of Industry & Regulators. Luther Gwaza PhD Consultant Feedback on SADC Workshop of Industry & Regulators Luther Gwaza PhD Consultant SADC WORKSHOP ON REGISTRATION OF MEDICINES & GOOD MANUFACTURING PRACTICE STANDARDS 11 TH 13 TH APRIL 2016, SOUTH AFRICA Brief

More information

Questions and answers on the procedure of PIP compliance verification at EMA, and on paediatric rewards

Questions and answers on the procedure of PIP compliance verification at EMA, and on paediatric rewards 15 December 2014 EMA/PDCO/179892/2011 Rev. 2 Product Development Scientific Support Paediatric Medicines Questions and answers on the procedure of PIP compliance verification at EMA, and on paediatric

More information

Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems. Outcome of 10 September 2012 Workshop

Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems. Outcome of 10 September 2012 Workshop Reflection Paper on Medicinal Product Supply Shortages Caused by Manufacturing/GMP Compliance Problems Outcome of 10 September 2012 Workshop Management Board Meeting - Agenda Point B10 04 October 2012

More information

Trends in the development of regulatory systems by the example of ICH countries

Trends in the development of regulatory systems by the example of ICH countries Trends in the development of regulatory systems by the example of ICH countries Author: Pär Tellner, Member of ICH Management Committee (ICH MC), EFPIA * Date: 27/08/2018 * GMP conference, Kazan, Russia

More information

Guidance for applicants requesting scientific advice

Guidance for applicants requesting scientific advice 7 December 2017 EMEA/CVMP/SAWP/172329/2004 Rev. 5 Veterinary Medicines Division Introduction The Scientific Advice Working Party (SAWP-V) of the Committee for Medicinal Products for Veterinary Use (CVMP)

More information

***I DRAFT REPORT. EN United in diversity EN. European Parliament 2018/0018(COD)

***I DRAFT REPORT. EN United in diversity EN. European Parliament 2018/0018(COD) European Parliament 2014-2019 Committee on the Environment, Public Health and Food Safety 4.5.2018 2018/0018(COD) ***I DRAFT REPORT on the proposal for a regulation of the European Parliament and of the

More information

Standard operating procedure

Standard operating procedure Standard operating procedure Title: Evaluation procedure for applications and requests for the establishment or review of Maximum Residue Limits (MRLs) Status: PUBLIC Document no.: SOP/V/4150 Lead author

More information

5.1 Demonstration Segment: Using the Workflow

5.1 Demonstration Segment: Using the Workflow Workflow: The Governance Approval Process CM includes a workflow tool which can be used to manage the proposal, submission and governance review process. Users can perform a number of functions in CM to

More information

Work plan for GCP Inspectors Working Group for 2018

Work plan for GCP Inspectors Working Group for 2018 22 March 2018 EMA/87812 /2018 Committees and Inspections Chairperson: Ana Rodriguez The activities outlined in the work plan for 2018 have been agreed in view of preparation for the Agency s relocation

More information

Safeguarding public health. The New PV Legislation. Perspective from a Member State

Safeguarding public health. The New PV Legislation. Perspective from a Member State Safeguarding public health The New PV Legislation Perspective from a Member State Mick Foy Reinforcing patient safety in Europe, Zagreb June 2011 Content Background The new EU PV Package ADR Definition

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Study Management and Handover SOP-RES-012 Version Number 3 Issue Date 19 th April 2017 Effective Date 2 nd June 2017 Review Date 2 nd June 2019 Author(s)

More information

Maintenance Review Board PR.MRB

Maintenance Review Board PR.MRB Name Validation Date Prepared by: Caroline RUGA Validated 08/06/2010 Verified by: Francis JOUVARD Validated 08/06/2010 Reviewed by: Véronique MAGNIER Validated 08/06/2010 Approved by: Evan NIELSEN Validated

More information

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE

INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE INTERNATIONAL CONFERENCE ON HARMONISATION OF TECHNICAL REQUIREMENTS FOR REGISTRATION OF PHARMACEUTICALS FOR HUMAN USE ICH HARMONISED TRIPARTITE GUIDELINE EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy

DRAFT OPINION. EN United in diversity EN. European Parliament 2018/0018(COD) of the Committee on Industry, Research and Energy European Parliament 2014-2019 Committee on Industry, Research and Energy 2018/0018(COD) 13.4.2018 DRAFT OPINION of the Committee on Industry, Research and Energy for the Committee on the Environment, Public

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Risk Assessment SOP-RES-002 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s) Reviewer(s)

More information

Procedure for handling applications for authorisation and review reports under REACH

Procedure for handling applications for authorisation and review reports under REACH Procedure for handling applications for authorisation and review reports under REACH 1. Purpose This procedure describes how to handle applications for authorisation (AfA) as established by the REACH Regulation

More information

SADC Collaborative Medicines Registration Initiative (Zazibona)

SADC Collaborative Medicines Registration Initiative (Zazibona) SADC Collaborative Medicines Registration Initiative (Zazibona) Dr Sinah Selelo Drugs Regulatory Unit Ministry of Health & Wellness GALVmed/OIE stakeholder workshop on the harmonisation of the registration

More information

ECHA and the implementation of REACH,CLP and other tasks

ECHA and the implementation of REACH,CLP and other tasks ECHA and the implementation of REACH,CLP and other tasks Eva Sandberg International Unit www.kemi.se ECHA, its tasks and organisation European Chemicals Agency ECHA REACH Regulation entered into force

More information

Electronic submission of information on medicinal products in accordance to Article 57(2) requirements: Maintenance submission

Electronic submission of information on medicinal products in accordance to Article 57(2) requirements: Maintenance submission Electronic submission of information on medicinal products in accordance to Article 57(2) requirements: Maintenance submission SME workshop: Focus on quality for medicines containing chemical entities

More information

Implementation of REACH & CLP: common challenges of national authorities and ECHA

Implementation of REACH & CLP: common challenges of national authorities and ECHA Implementation of REACH & CLP: common challenges of national authorities and ECHA Finnish Safety and Chemicals Agency (Tukes); Opening Seminar 9 February 2011, Tampere Geert Dancet Executive Director Content

More information

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES

NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES NEWCASTLE CLINICAL TRIALS UNIT STANDARD OPERATING PROCEDURES SOP details SOP title: Risk Assessment of NCTU Studies SOP number: TM-020 SOP category: Trial Management Version number: 02 Version date: 16

More information

Applicants are reminded that the

Applicants are reminded that the ISSUE NO 18 May August 2004 M E D I C I N A L P R O D U C T S SEPTEMBER DECEMBER 2009 Issue No. 34 IRISH MEDICINES BOARD, KEVIN O MALLEY HOUSE, EARLSFORT CENTRE, EARLSFORT TERRACE, DUBLIN 2 TEL: 01 676

More information

The implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium. and impact on the ethical review process

The implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium. and impact on the ethical review process 1 The implementation of the Clinical Trial Regulation (CTR, n 536/2014) in Belgium and impact on the ethical review process 2 1. Clinical Trials on Medicinal Products for Human Use: Change of the Legal

More information

Guideline on good pharmacovigilance practices (GVP)

Guideline on good pharmacovigilance practices (GVP) 1 2 26 July 2012 EMA/118465/2012 3 4 Guideline on good pharmacovigilance practices (GVP) Module XV Safety communication 5 Draft finalised by the Agency in collaboration with Member States and submitted

More information

CLP the implementation of GHS in the EU Facts and practical advice

CLP the implementation of GHS in the EU Facts and practical advice CLP the implementation of GHS in the EU Facts and practical advice Seminar on the latest trend regarding revised CSCL, REACH and CLP 30 March 2010, Tokyo Gabriele Schöning ECHA Classification Unit Content

More information

INTERNATIONAL CONSULTATION AND ANALYSIS

INTERNATIONAL CONSULTATION AND ANALYSIS INTERNATIONAL CONSULTATION AND ANALYSIS 2015 Secretariat All rights reserved. This publication is issued for public information purposes and is not an official text of the Convention in any legal or technical

More information

Safeguarding public health. The New PV Legislation its Impact on PV & MI

Safeguarding public health. The New PV Legislation its Impact on PV & MI Safeguarding public health The New PV Legislation its Impact on PV & MI Sarah Vaughan - MHRA PIPA 2013 Manager s Meeting 13 th February 2013 Content Scope of change Key areas - ADR reporting - DDPS to

More information

European CE Marking of Medical Devices. October 2017

European CE Marking of Medical Devices. October 2017 European CE Marking of Medical Devices October 2017 1 2017 EU Regulations Why? Response to scandals to restore confidence in system Keep pace with scientific and technical developments Overcome divergence

More information

- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation

- Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation - Proposal for a Regulation on HTA- Ioana Siska, MD, PhD DG SANTE - Health Systems and Products Medical Products: safety, quality, innovation Pharma Committee meeting, 8 March 2018 Background More than

More information

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Safety of the food chain Chemicals, contaminants, pesticides

EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL. Safety of the food chain Chemicals, contaminants, pesticides 1 EUROPEAN COMMISSION HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL Safety of the food chain Chemicals, contaminants, pesticides SANCO/12545/2014 rev. 2 March 2016 GUIDANCE DOCUMENT FOR APPLICANTS ON

More information

Questions and answers about Recycling Processes

Questions and answers about Recycling Processes Questions and answers about Recycling Processes 1. How do I apply for an authorisation for a plastic recycling process? 1. You should draw up an application following the European Food Safety Authority

More information

Topical Peer Review 2017 Ageing Management of Nuclear Power Plants

Topical Peer Review 2017 Ageing Management of Nuclear Power Plants HLG_p(2016-33)_348 Topical Peer Review 2017 Ageing Management of Nuclear Power Plants Terms of Reference for Topical Peer Review Process This paper provides the terms of reference for the peer review of

More information

STANDARD OPERATING PROCEDURE

STANDARD OPERATING PROCEDURE STANDARD OPERATING PROCEDURE Title Reference Number Corrective and Preventative Action SOP-QMS-008 Version Number 2 Issue Date 29 th Sep 2016 Effective Date 10 th Nov 2016 Review Date 10 th Nov 2018 Author(s)

More information

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo

Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics Oslo Commission Guidelines for the implementation of the Clinical Trials Regulation NTA Ethics 30.1.2017 Oslo 3.2.2017 O. Konttinen 1 Background Based on directive 2001/20/EC of the clinical trials on medicinal

More information

Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force

Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force 5 May 2017 EMA/180341/2017 Inspections, Human Medicines, Pharmacovigilance and Committees Division Patient Registry Initiative- Strategy and Mandate of the Cross-Committee Task Force EMA Initiative 1.

More information

Role of the Nursing Home Medical Director. Vicky Pilkington, MD, CMD

Role of the Nursing Home Medical Director. Vicky Pilkington, MD, CMD Role of the Nursing Home Medical Director Vicky Pilkington, MD, CMD DEFINITIONS Attending Physician refers to the physician who has the primary responsibility for the medical care of a resident. Medical

More information

Biocidal product regulation the changes to come

Biocidal product regulation the changes to come Biocidal product regulation the changes to come The Biocidal Product Regulation, which came into force on 1 September 2013 is still changing. ECHA announced the evolutions of this changing regulation during

More information

Intra-Africa Academic Mobility Scheme. Workshop 2 Promotion and Selection EACEA A.3. Elena PALAVROVA

Intra-Africa Academic Mobility Scheme. Workshop 2 Promotion and Selection EACEA A.3. Elena PALAVROVA Intra-Africa Academic Mobility Scheme Workshop 2 Promotion and Selection Elena PALAVROVA EACEA A.3 2017 Projects' Kick-Off Meeting Brussels, 5-6 February 2018 Image :: Shutterstock.com DEVCO European Commission

More information

Lessons from the EMA Patient Registries Initiative

Lessons from the EMA Patient Registries Initiative Lessons from the EMA Patient Registries Initiative STAMP Commission Expert Group 8 th June 2018 Presented by Peter Arlett, with contributions from Patricia McGettigan and Jane Moseley Head of Pharmacovigilance

More information

EUROPEAN COMMISSION. CALL - EAC/A06/2017 Erasmus+ Vocational Education and Training Mobility Charter

EUROPEAN COMMISSION. CALL - EAC/A06/2017 Erasmus+ Vocational Education and Training Mobility Charter Ref. Ares(2017)5680072-21/11/2017 1. EUROPEAN COMMISSION CALL - EAC/A06/2017 Erasmus+ Vocational Education and Training Mobility Charter 1. Introduction This specific Call is based on Regulation (EU) No

More information

Health and Safety Authority. Function and Scope of REACH and CLP Helpdesks

Health and Safety Authority. Function and Scope of REACH and CLP Helpdesks Rev 1. June 2009 Health and Safety Authority Function and Scope of REACH and CLP Helpdesks Introduction The EU Regulation for Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH)

More information

Regulation 347/2013 as adopted and adapted in the Energy Community

Regulation 347/2013 as adopted and adapted in the Energy Community Regulation 347/2013 as adopted and adapted in the Energy Community Adam Cwetsch International relations & Enlargement DG ENERGY, European Commission 26/02/ GOALS Regulatory framework to improve investment

More information

Market Access for Food Supplements: EHPM Country Profiles. Mr Patrick Ahern Director General EHPM

Market Access for Food Supplements: EHPM Country Profiles. Mr Patrick Ahern Director General EHPM Market Access for Food Supplements: EHPM Country Profiles Mr Patrick Ahern Director General EHPM EHPM European federation of National Associations of Health Product Manufacturers Established 1975, 13 members,

More information

Application Form. Green Infrastructure Fund

Application Form. Green Infrastructure Fund Application Form Green Infrastructure Fund January 2016 Application Form For guidance on completing this form, please refer to the Green Infrastructure Fund Application Form Guidance which explains the

More information

Technical Report No. 68 Risk-Based Approach for Prevention and Management of Drug Shortages

Technical Report No. 68 Risk-Based Approach for Prevention and Management of Drug Shortages Technical Report No. 68 Risk-Based Approach for Prevention and Management of Drug Shortages Paradigm Change in Manufacturing Operations PDA Risk-Based Approach for Prevention and Management of Drug Shortages

More information

Final Draft Agenda Sixteenth meeting of the Forum for Exchange of Information on Enforcement (Forum-16) October 2013

Final Draft Agenda Sixteenth meeting of the Forum for Exchange of Information on Enforcement (Forum-16) October 2013 18 October 2013 ECHA/Forum-16/2013/A/final Final Draft Agenda Sixteenth meeting of the Forum for Exchange of Information on Enforcement (Forum-16) 28-31 October 2013 European Chemicals Agency Helsinki,

More information

ASSEMBLY AGENDA PAPERS. May 31 & June 1, 2017 Montreal, Canada

ASSEMBLY AGENDA PAPERS. May 31 & June 1, 2017 Montreal, Canada ASSEMBLY AGENDA PAPERS May 31 & June 1, 2017 Montreal, Canada Dated May 16, 2017 ICH2017/04 ICH ASSEMBLY MEETING Final DRAFT AGENDA May 31 & June 1, 2017 Montreal, Canada Opening of the ICH Assembly Meeting

More information

Improving Care and Lowering Costs for Dual Eligible Beneficiaries

Improving Care and Lowering Costs for Dual Eligible Beneficiaries Improving Care and Lowering Costs for Dual Eligible Beneficiaries An Overview of Federal and State Efforts on Duals and Suggested Strategies to Position PACE National PACE Association September 13, 2011

More information

GUIDE FOR ACTION GRANTS 2015

GUIDE FOR ACTION GRANTS 2015 Guide for Action Grants 2015 Version: June 2015 EUROPEAN COMMISSION DIRECTORATE-GENERAL JUSTICE and CONSUMERS Directorate A Unit A4: Programme management GUIDE FOR ACTION GRANTS 2015 *** Justice Programme

More information

Accelerated procedure for registration of WHO-prequalified medicines = Collaboration Procedure between the WHO Prequalification Programme and NMRAs

Accelerated procedure for registration of WHO-prequalified medicines = Collaboration Procedure between the WHO Prequalification Programme and NMRAs Accelerated procedure for registration of WHO-prequalified medicines = Collaboration Procedure between the WHO Prequalification Programme and NMRAs Lembit Rägo/Milan Smid WHO Prequalification of Medicines

More information

European Maritime Safety Agency. Training on Maritime Security October Obligations for. Maritime Administrations

European Maritime Safety Agency. Training on Maritime Security October Obligations for. Maritime Administrations European Maritime Safety Agency Training on Maritime Security 26-27 October 2010 1 Obligations for Maritime Administrations in respect of Ship Security Overview 1. EU Maritime Security Legislation 2. Role

More information

BETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS

BETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS A2 BETTER REGULATION OF MEDICINES INITIATIVE (BROMI): FIFTH REPORT ON PROGRESS March 2012 A3 BETTER REGULATION OF MEDICINES INITIATIVE (BROMI) FIFTH REPORT ON PROGRESS Chief Executive s foreword In January

More information

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals

European IVD Regulations and Risk Based Classification. An Overview for Global Quality Professionals European IVD Regulations and Risk Based Classification An Overview for Global Quality Professionals Anna Sadio IVD Technical Expert/Project Manager Oct 2013 Caution The new regulations are draft and subject

More information

Integration Scheme. Between. Glasgow City Council. and. NHS Greater Glasgow and Clyde

Integration Scheme. Between. Glasgow City Council. and. NHS Greater Glasgow and Clyde Integration Scheme Between Glasgow City Council and NHS Greater Glasgow and Clyde December 2015 Page 1 of 60 1. Introduction 1.1 The Public Bodies (Joint Working) (Scotland) Act 2014 (the Act) requires

More information

Application Form Green Infrastructure Fund

Application Form Green Infrastructure Fund Application Form Green Infrastructure Fund Round 2 July 2016 Application Form For guidance on completing this form, please refer to the Green Infrastructure Fund Application Form Guidance which explains

More information

Guidance on the Biocidal Products Regulation

Guidance on the Biocidal Products Regulation G U I D A N C E Guidance on the Biocidal Products Regulation Volume V, Guidance on active substances and suppliers (Article 95 list) Version 2.1 March 2017 2 Guidance on BPR: Volume V Version 2.1 March

More information

The Classification and Labelling Inventory. Cefic s viewpoint

The Classification and Labelling Inventory. Cefic s viewpoint The Classification and Labelling Inventory Cefic s viewpoint Marie-Pierre Rabaud RIEF III Brussels 24 June 2014 The C&L Inventory Improvement of the C&L Inventory is a need Industry to consider ways to

More information

A Dedicated Post Authorisation Measure Submission Form

A Dedicated Post Authorisation Measure Submission Form A Dedicated Post Authorisation Measure Submission Form An improved way of submitting your PAM to the EMA Presented by Hector Boix Perales on 03 July 2017 Procedure Management Department Human Medicines

More information

REPUBLIC OF SERBIA Bilateral screening: Chapter 1 Free Movement of Goods. C L P Classification, Labeling and Packaging of substances and mixtures

REPUBLIC OF SERBIA Bilateral screening: Chapter 1 Free Movement of Goods. C L P Classification, Labeling and Packaging of substances and mixtures REPUBLIC OF SERBIA Bilateral screening: C L P Classification, Labeling and Packaging of substances and mixtures C O N T E N T STATE OF PLAY LEGISLATIVE FRAMEWORK COMPETENT AUTHORITY (CA) ADMINISTRATIVE

More information

Opinion No 13/2016. Technical records

Opinion No 13/2016. Technical records European Aviation Safety Agency Opinion No 13/2016 Technical records RELATED NPA/CRD 2014-04 RMT.0276 (MDM.076) EXECUTIVE SUMMARY Technical records are the means to assess the airworthiness status of an

More information

Guidance notes for patient safety and pharmacovigilance in patient support programmes

Guidance notes for patient safety and pharmacovigilance in patient support programmes Guidance notes for patient safety and pharmacovigilance in patient support programmes Authors: The ABPI Pharmacovigilance Expert Network Version: 2.14 Date: March 2018 Acknowledgements: We thank the many

More information

Knowledge Exchange and Dissemination Scheme

Knowledge Exchange and Dissemination Scheme Knowledge Exchange and Dissemination Scheme Supplementary Award for Accelerating Impact 2018 Guidance Notes Key dates Call open to applicants 01 June 2018 Deadline for submission of applications 27 July

More information

Guidance on the preparation of dossiers for harmonised classification and labelling (CLH) under Regulation (EC) No.

Guidance on the preparation of dossiers for harmonised classification and labelling (CLH) under Regulation (EC) No. Guidance on the preparation of dossiers for harmonised classification and labelling (CLH) under Regulation (EC) No. 1272/2008 DRAFT LEGAL NOTICE This document contains guidance to the preparation of dossiers

More information

Bilateral screening: Chapter 27 PRESENTATION OF THE REPUBLIC OF SERBIA Classification, labelling and packaging of substances and mixtures - CLP

Bilateral screening: Chapter 27 PRESENTATION OF THE REPUBLIC OF SERBIA Classification, labelling and packaging of substances and mixtures - CLP REPUBLIC OF SERBIA Negotiating Group for the Chapter 27 Environment and Climate Change Bilateral screening: Chapter 27 PRESENTATION OF THE REPUBLIC OF SERBIA Classification, labelling and packaging of

More information

ICH Topic Q4B Annex 6 Uniformity of Dosage Units General Chapter. Step 3

ICH Topic Q4B Annex 6 Uniformity of Dosage Units General Chapter. Step 3 European Medicines Agency December 2008 EMEA/CHMP/ICH/645408/2008 ICH Topic Q4B Annex 6 Uniformity of Dosage Units General Chapter Step 3 ANNEX 6 TO NOTE FOR EVALUATION AND RECOMMENDATION OF PHARMACOPOEIAL

More information

Page 1 of 5 Version No: 6 Authorised by: General Counsel

Page 1 of 5 Version No: 6 Authorised by: General Counsel Feedback Action Analysis Prioritisation Classificattion Notification Identification INCIDENT MANAGEMENT Patient informed / Family informed if required Event occurs If staff injury form must be printed,

More information

ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014

ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014 Management Board Decision 07/2015 1(5) ASSESSMENT OF THE CONSOLIDATED ANNUAL ACTIVITY REPORT OF THE AUTHORISING OFFICER FOR THE YEAR 2014 THE MANAGEMENT BOARD, Having regard to Regulation (EC) No 1907/2006

More information

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines

NHS Lanarkshire Policy for the Availability of Unlicensed Medicines NHS Lanarkshire Policy for the Availability of Unlicensed Medicines Prepared by: NHS Lanarkshire Chief Pharmacist Endorsed by: Area Drug & Therapeutic Committee Previous Version/Date: Primary Policy Date:

More information

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS

European Medicines Agency Inspections ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS European Medicines Agency Inspections London, 23 July 2008 EMEA/INS/GCP/197215/2005 Procedure no.: INS/GCP/3/V ANNEX V TO PROCEDURE FOR CONDUCTING GCP INSPECTIONS REQUESTED BY THE EMEA: PHASE I UNITS GCP

More information

What s Next for CMS Innovation Center?

What s Next for CMS Innovation Center? What s Next for CMS Innovation Center? A Guide to Building Successful Value-Based Payment Models Given CMMI s New Focus on Voluntary, Home-Grown Initiatives W W W. H E A L T H M A N A G E M E N T. C O

More information

State Policy Update. Liz Parry and Linda Shaw

State Policy Update. Liz Parry and Linda Shaw State Policy Update Liz Parry and Linda Shaw Overview Context of PACE and State Policy Role of State PACE Associations NPA s State Policy Priorities for PACE Growth of PACE PACE Sustainability Oversight

More information

TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES

TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES TESTIMONY OF THOMAS HAMILTON DIRECTOR SURVEY & CERTIFICATION GROUP CENTER FOR MEDICAID AND STATE OPERATIONS CENTERS FOR MEDICARE & MEDICAID SERVICES ON CLIA AND GENETIC TESTING BEFORE THE SENATE SPECIAL

More information

Regulatory Conference: KEY TAKE- AWAYS. Engela Dedwith, Eli Lilly

Regulatory Conference: KEY TAKE- AWAYS. Engela Dedwith, Eli Lilly 2 nd African Regulatory Conference: KEY TAKE- AWAYS Engela Dedwith, Eli Lilly CONFERENCE TOPICS 1. Regulatory Harmonisation 2. The Global Regulatory Environment 3. The Value of Research and Development

More information

SUMMARY OF THE INDUSTRY TASK GROUP MEETING HELD AT 08:00 ON 23 JUNE 2015 IN THE CIVITAS BUILDING

SUMMARY OF THE INDUSTRY TASK GROUP MEETING HELD AT 08:00 ON 23 JUNE 2015 IN THE CIVITAS BUILDING SUMMARY OF THE INDUSTRY TASK GROUP MEETING HELD AT 08:00 ON 23 JUNE 2015 IN THE CIVITAS BUILDING Present MRA/DoH Joey Gouws (JG) Estelle Taute (ET) Ndimuhulu Dowelani (ND) Shyamli Munbodh (SM) Jerry Molokwane

More information